The Beachwood-based company announced on Tuesday, May 20, that it has appointed Dr. David Llewellyn as its new CEO and as a ...

Tucked away on the north edge of Jacksonville, surrounded by farm fields, sits a large facility where a small team assembles ...

Greenhaven Road Capital, an investment management company, released its first-quarter 2025 investor letter. A copy of the ...

Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, T2D and other metabolic diseases.

Fintel reports that on May 21, 2025, William Blair initiated coverage of Lifecore Biomedical (NasdaqGS:LFCR) with a ...

Plus: Rockville man arrested for filming woman in fitting room at Montgomery mall; Montgomery College launches cybersecurity ...

Dr. Aaron Carrithers brings a founder’s mindset and extensive firsthand experience, guiding biotech teams through complicated ...

New Orleans biotech South Rampart Pharma advances non-opioid pain drug with $8M funding from Ochsner Ventures and Gulf South ...

SANOFI will acquire Vigil Neuroscience, a clinical-stage biotech company in a $470-million deal, the companies said on Thursday, as the French drugmaker seeks to boost its neurological pipeline ...

Only three months after banking an eye-popping $350 million series D round, Eikon Therapeutics is blaming government funding ...

From my colleague Adam Feuerstein: French drug maker Sanofi is acquiring the small biotech Vigil Neuroscience for $470 ...

Despite these positive clinical developments, Amgen and Viking Therapeutics have performed poorly on the stock market in the past 12 months, though progress in this area might eventually help them ...